...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: something. anything.

Mighty quiet on the Zenith front.  I thought some major changes were "imminent".

Share
New Message
Please login to post a reply